(Q44133263)

30 November 2017

title

Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy (English)

1 reference

30 November 2017

Buhmann C

1

1 reference

30 November 2017

Gbadamosi J

series ordinal

2

1 reference

30 November 2017

Heesen C

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Acta Neurologica Scandinavica

30 November 2017

published in

1 reference

30 November 2017

volume

106

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

236-239

1 reference

mtDNA mutations in Leber's hereditary optic neuropathy

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Variable pattern of visual recovery of Leber's hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Bilateral optic neuritis. A long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber hereditary optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

Treatment of multiple sclerosis with mitoxantrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

Association of the 11778 mitochondrial DNA mutation and demyelinating disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

LHON mutations in Italian patients affected by multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

A Controlled Trial of Mitoxantrone in Multiple Sclerosis: Serial MRI Evaluation at One Year

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01323.X

7 January 2021

10.1034/J.1600-0404.2002.01323.X

Identifiers

DOI

1 reference

30 November 2017

1 reference